Sector Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 19/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.210 USD | -0.31% |
|
+0.94% | +16.73% |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| 11/08 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 37Cr | - | ||||
| 4.88TCr | |||||
| 4.54TCr | - | - | - | - | - |
| 4.12TCr | |||||
| 3.97TCr | |||||
| 3.26TCr |
Select your edition
All financial news and data tailored to specific country editions
